TIFA anticorps (AA 1-184) (HRP)
-
- Antigène Voir toutes TIFA Anticorps
- TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))
-
Épitope
- AA 1-184
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TIFA est conjugé à/à la HRP
-
Application
- ELISA
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human TRAF-interacting protein with FHA domain-containing protein A protein (1-184AA)
- Isotype
- IgG
- Top Product
- Discover our top product TIFA Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))
- Autre désignation
- TIFA (TIFA Produits)
- Synonymes
- anticorps TIFA, anticorps xtifa, anticorps T2BP, anticorps T6BP, anticorps TIFAA, anticorps T2bp, anticorps Ab2-389, anticorps TRAF interacting protein with forkhead associated domain, anticorps TRAF-interacting protein with forkhead-associated domain, anticorps TRAF-interacting protein with forkhead-associated domain S homeolog, anticorps TIFA, anticorps tifa, anticorps Tifa, anticorps tifa.S
- Sujet
-
Background: Adapter protein which mediates the IRAK1 and TRAF6 interaction following IL-1 stimulation, resulting in the downstream activation of NF-kappa-B and AP-1 pathways. Induces the oligomerization and polyubiquitination of TRAF6, which leads to the activation of TAK1 and IKK through a proteasome-independent mechanism.
Aliases: Putative MAPK activating protein PM14 antibody, Putative MAPK-activating protein PM14 antibody, Putative NF kappa B activating protein 20 antibody, Putative NF-kappa-B-activating protein 20 antibody, T2BP antibody, TIFA antibody, TIFA_HUMAN antibody, TRAF interacting protein with FHA domain containing protein A antibody, TRAF-interacting protein with FHA domain-containing protein A antibody, TRAF2 binding protein antibody, TRAF2-binding protein antibody
- UniProt
- Q96CG3
-